O

Odyssey Therapeutics

157 employees

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2021

Funding rounds raised

Total raised

$218M

from 14 investors over 14 rounds

O

Odyssey Therapeutics raised $168M on October 13, 2022

Investors: Walleye Capital, SVB Securities, Logos Global Management, LP, General Catalyst, OrbiMed Advisors, Woodline Partners LP, GreatPoint Ventures, S.R. One Ltd and T. Rowe Price

O

Odyssey Therapeutics raised $218M on December 7, 2021

Investors: S.R. One Ltd, OrbiMed Advisors, Logos Global Management, LP, Foresite Capital and Woodline Partners LP

FAQ